Advanced search
Publication Cover
Cancer Biology & Therapy Volume 7, 2008 - Issue 11
Submit an article Journal homepage
288
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

scFv-Mediated delivery of truncated BID suppresses HER2-positive osteosarcoma growth and metastasis

Le-Qun Shan
,
Xiu-Chun Qiu
,
Yan-Ming Xu
,
Zheng-Gang Ji
,
Tong-Tao Yang
,
Xiang Chen
,
Bao-An Ma
,
Yong Zhou
,
Qing-Yu Fan
&
An-Gang Yang
 show all
Pages 1717-1722 | Published online: 01 Nov 2008

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Haya Lorberboum-Galski. (2011) Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases. Expert Opinion on Drug Delivery 8:5, pages 605-621.
Read now

Articles from other publishers (5)

Parisa Meysami, Farhad Rezaei, Sayed Mahdi Marashi, Mohammad Mehdi Amiri, Emyr Bakker & Talat Mokhtari-Azad. (2019) Antitumor effects of a recombinant baculovirus displaying anti-HER2 scFv expressing Apoptin in HER2 positive SK-BR-3 breast cancer cells. Future Virology 14:3, pages 139-152.
Crossref
Naroa Serna, Laura Sánchez-García, Ugutz Unzueta, Raquel Díaz, Esther Vázquez, Ramón Mangues & Antonio Villaverde. (2018) Protein-Based Therapeutic Killing for Cancer Therapies. Trends in Biotechnology 36:3, pages 318-335.
Crossref
Edward L Nelson. (2014) HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations. Clinical Investigation 4:9, pages 791-823.
Crossref
Alejandro Sosnik & Angel M. Carcaboso. (2014) Nanomedicines in the future of pediatric therapy. Advanced Drug Delivery Reviews 73, pages 140-161.
Crossref
Yu Cao & Michael G. Rosenblum. 2013. Antibody-Drug Conjugates and Immunotoxins. Antibody-Drug Conjugates and Immunotoxins 319 348 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.